13:15 – 13:30 h - Welcome and introduction by the chairs
Chairs: Oscar Della Pasqua and Vincent Dubois

13:30 – 13:55 h - QTc prolongation and characterisation of torsadogenic effects of drug candidates
Speaker: Derek Leishman, Eli Lilly, USA

13:55 – 14:25 h – Overview of the ICH E14 guideline – perspectives from industry
Speaker: Charles Benson, Eli Lilly, USA

14:25 – 14:55 h - Overview of the ICH E14 guideline and scientific rationale for using C-QTc modelling as primary analysis Speaker: Jiang Liu, CDER, FDA, USA

14:55 -15:25 h - Modelling the C-QTc relationship with Case Examples (1)—Technical Discussion of Model, Model Selection, Goodness-of-fit, and Model Predictions
Speaker: Anne S Chain, Merck, USA

15:25 -15:50 h - Coffee break

15:50 – 16:15 h - Modelling the C-QTc relationship with Case Examples (2)—Technical Discussion of Model, Model Selection, Goodness-of-fit, and Model Predictions
Speaker: Georg Ferber, Statistik Georg Ferber GmbH, Switzerland

16:15 -16:45 h - Regulatory evaluation of CQTc modelling results
Speaker: Flora Musuamba, Modelling & Simulation Working Group, EMA, UK

16:45 -17:20 h - Round table
All speakers

17:20 -17:30 h - Wrap-up and closure

Personal data will be processed according to Data Protection Act 1998.
The data collected above will be held for the purposes of communications regarding this event only.

Your name will be included in the participants list.

Registration is free of charge. However, contact the organising committee as soon as possible to cancel your enrolment if you are not able to attend the event.